Literature DB >> 19729438

Combination of peritubular c4d and transplant glomerulopathy predicts late renal allograft failure.

Niamh Kieran1, Xiaotong Wang, James Perkins, Connie Davis, Elizabeth Kendrick, Ramaswamy Bakthavatsalam, Nancy Dunbar, Paul Warner, Karen Nelson, Kelly D Smith, Roberto F Nicosia, Charles E Alpers, Nicolae Leca, Jolanta Kowalewska.   

Abstract

The histologic associations and clinical implications of peritubular capillary C4d staining from long-term renal allografts are unknown. We identified 99 renal transplant patients who underwent an allograft biopsy for renal dysfunction at least 10 yr after transplantation, 25 of whom were C4d-positive and 74 of whom were C4d-negative. The average time of the index biopsy from transplantation was 14 yr in both groups. Compared with C4d-negative patients, C4d-positive patients were younger at transplantation (29 +/- 13 versus 38 +/- 12 yr; P < 0.05) and were more likely to have received an allograft from a living donor (65 versus 35%; P < 0.001). C4d-positive patients had more inflammation, were more likely to have transplant glomerulopathy, and had worse graft outcome. The combined presence of C4d positivity, transplant glomerulopathy, and serum creatinine of >2.3 mg/dl at biopsy were very strong predictors of rapid graft loss. C4d alone did not independently predict graft loss. Retrospective staining of historical samples from C4d-positive patients demonstrated C4d deposition in the majority of cases. In summary, these data show that in long-term renal allografts, peritubular capillary staining for C4d occurs in approximately 25% of biopsies, can persist for many years after transplantation, and strongly predicts graft loss when combined with transplant glomerulopathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19729438      PMCID: PMC2754096          DOI: 10.1681/ASN.2009020199

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  42 in total

1.  Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications.

Authors:  Volker Nickeleit; Matthias Zeiler; Fred Gudat; Gilbert Thiel; M J Mihatsch
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

2.  Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection.

Authors:  H Regele; M Exner; B Watschinger; C Wenter; M Wahrmann; C Osterreicher; M D Säemann; N Mersich; W H Hörl; G J Zlabinger; G A Böhmig
Journal:  Nephrol Dial Transplant       Date:  2001-10       Impact factor: 5.992

3.  C4d deposition in acute rejection: an independent long-term prognostic factor.

Authors:  Andrew M Herzenberg; John S Gill; Ognjenka Djurdjev; Alex B Magil
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

4.  Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury.

Authors:  Georg A Böhmig; Markus Exner; Antje Habicht; Martin Schillinger; Ursula Lang; Josef Kletzmayr; Marcus D Säemann; Walter H Hörl; Bruno Watschinger; Heinz Regele
Journal:  J Am Soc Nephrol       Date:  2002-04       Impact factor: 10.121

5.  Transplant glomerulopathy as a cause of late graft loss.

Authors:  D L Suri; S J Tomlanovich; J L Olson; T W Meyer
Journal:  Am J Kidney Dis       Date:  2000-04       Impact factor: 8.860

6.  Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries.

Authors:  Shamila Mauiyyedi; Patricia Della Pelle; Susan Saidman; A Bernard Collins; Manuel Pascual; Nina E Tolkoff-Rubin; Winfred W Williams; A Benedict Cosimi; Eveline E Schneeberger; Robert B Colvin
Journal:  J Am Soc Nephrol       Date:  2001-03       Impact factor: 10.121

7.  The UNOS Scientific Renal Transplant Registry--2000.

Authors:  J M Cecka
Journal:  Clin Transpl       Date:  2000

8.  Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification.

Authors:  Shamila Mauiyyedi; Marta Crespo; A Bernard Collins; Eveline E Schneeberger; Manuel A Pascual; Susan L Saidman; Nina E Tolkoff-Rubin; Winfred W Williams; Francis L Delmonico; A Benedict Cosimi; Robert B Colvin
Journal:  J Am Soc Nephrol       Date:  2002-03       Impact factor: 10.121

9.  Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels.

Authors:  Naim Issa; Fernando G Cosio; James M Gloor; Sanjeev Sethi; Patrick G Dean; S Breanndan Moore; Steve DeGoey; Mark D Stegall
Journal:  Transplantation       Date:  2008-09-15       Impact factor: 4.939

10.  Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection.

Authors:  Heinz Regele; Georg A Böhmig; Antje Habicht; Daniela Gollowitzer; Martin Schillinger; Susanne Rockenschaub; Bruno Watschinger; Dontscho Kerjaschki; Markus Exner
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

View more
  22 in total

1.  Dimensions of antibody-mediated rejection.

Authors:  R B Colvin
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

2.  Presentation and Outcomes of C4d-Negative Antibody-Mediated Rejection After Kidney Transplantation.

Authors:  B J Orandi; N Alachkar; E S Kraus; F Naqvi; B E Lonze; L Lees; K J Van Arendonk; C Wickliffe; S M Bagnasco; A A Zachary; D L Segev; R A Montgomery
Journal:  Am J Transplant       Date:  2015-08-28       Impact factor: 8.086

Review 3.  Chronic alloantibody mediated rejection.

Authors:  R Neal Smith; Robert B Colvin
Journal:  Semin Immunol       Date:  2011-11-02       Impact factor: 11.130

4.  Acute transplant glomerulopathy with monocyte rich infiltrate.

Authors:  Colin R Lenihan; Jane C Tan; Neeraja Kambham
Journal:  Transpl Immunol       Date:  2013-09-19       Impact factor: 1.708

Review 5.  Emerging role of B cells in chronic allograft dysfunction.

Authors:  Robert B Colvin; Tsutomu Hirohashi; Alton B Farris; Francesca Minnei; A Bernard Collins; R Neal Smith
Journal:  Kidney Int Suppl       Date:  2010-12       Impact factor: 10.545

Review 6.  Clinical role of the renal transplant biopsy.

Authors:  Winfred W Williams; Diana Taheri; Nina Tolkoff-Rubin; Robert B Colvin
Journal:  Nat Rev Nephrol       Date:  2012-01-10       Impact factor: 28.314

7.  Archetype Analysis Identifies Distinct Profiles in Renal Transplant Recipients with Transplant Glomerulopathy Associated with Allograft Survival.

Authors:  Olivier Aubert; Sarah Higgins; Yassine Bouatou; Daniel Yoo; Marc Raynaud; Denis Viglietti; Marion Rabant; Luis Hidalgo; Denis Glotz; Christophe Legendre; Michel Delahousse; Nikhil Shah; Banu Sis; Patricia Campbell; Michael Mengel; Xavier Jouven; Jean-Paul Duong Van Huyen; Carmen Lefaucheur; Alexandre Loupy
Journal:  J Am Soc Nephrol       Date:  2019-03-14       Impact factor: 10.121

8.  Optimal cutoff point for immunoperoxidase detection of C4d in the renal allograft: results from a multicenter study.

Authors:  Gretchen S Crary; Yassaman Raissian; Robert C Gaston; Sita M Gourishankar; Robert E Leduc; Roslyn B Mannon; Arthur J Matas; Joseph P Grande
Journal:  Transplantation       Date:  2010-11-27       Impact factor: 4.939

9.  Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts.

Authors:  R Neal Smith; Fahim Malik; Nelson Goes; Alton B Farris; Emmanuel Zorn; Susan Saidman; Nina Tolkoff-Rubin; Sonika Puri; Waichi Wong
Journal:  Transpl Immunol       Date:  2012-08-30       Impact factor: 1.708

Review 10.  Transplant glomerulopathy.

Authors:  Edward J Filippone; Peter A McCue; John L Farber
Journal:  Mod Pathol       Date:  2017-10-13       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.